Neurology researchers at Nottingham are studying how artificial intelligence can help plan treatment for people with multiple sclerosis. Nikos Evangelou, Professor of Neurology at the University of Nottingham and honorary consultant Neurologist at Nottingham University Hospitals NHS Trust said: "As part of monitoring patients with Multiple Sclerosis, we do lots...
West Midlands Innovation Accelerator to Spark Growth and Innovation
The West Midlands Combined Authority (WMCA) prepares to launch the West Midlands Innovation Accelerator to bolster the region’s innovation and R&D capability and capacity to spark commercial growth and investment. First announced in the Government’s 2022 Levelling up White Paper, the West Midlands Innovation Accelerator will commence in May 2023, funded...
Medilink Midlands Business Awards 2023 Winners
Previous Next The Medilink Midlands Business Awards 2023, sponsored by the University of Birmingham and the Precision Health Technologies Accelerator Ltd, were held last night and saw thirteen life science companies based in the East and West Midlands receive awards from Start-Up to Outstanding Achievement. A further six companies received...
UK Budget 2023 – Life Sciences Update
The Chancellor of the Exchequer presented his Spring Budget to Parliament on Wednesday 15 March 2023. This Spring Budget highlights the following points for the whole of the life science industry. A lot of emphasis has been given to the UK becoming Global Leader in Science initiatives. The Government could work on...
Polyflon Medical launches new website
Polyflon Medical, UK medical tubing component specialists, have unveiled their brand new website redesign. The company, with over 30 years of experience in the engineering of polymer materials, relaunched their website in order to create a more seamless visitor experience and showcase their range of medical tube components in a...
Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed’s HS-001 investigational cell therapy as its first in-human trial commences
Albumedix Ltd ('Albumedix'), Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc ('Heartseed'), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin® is a critical component of Heartseed's HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing. Recombumin, an animal and human...
Medilink Midlands: New Appointments Announced
The Board of Medilink Midlands is delighted to announce two major new appointments. Melanie Davidson has been appointed Interim Chief Executive Officer, and Andrea Dawson as Chief Operating Officer/Chief Finance Officer with immediate effect. Simon Himsworth the previous Chief Executive Officer has now moved onto newer pastures, and we wish...
eg technology look to the future as they become employee owned
With great pleasure, co-founders Andrew Ede and Danny Godfrey announce that eg technology Ltd have made the transition to employee ownership. This significant move, coming as eg mark their twenty-first anniversary, will ensure the stability and long-term security of the company going forward whilst giving every employee an ownership interest...
EU MDR Roadway
A lot of buzz is going around EU MDR and it’s proposed transitional Deadlines. While these deadlines apply only to a certain Risk class of Medical Devices and do not apply to all Medical Manufacturers. Read about the details by clicking here Irrespective of whether the proposal falls in place, Medical...
Shakespeare Martineau strengthens Birmingham funding offering
Full-service law firm Shakespeare Martineau has bolstered its building communities offering in Birmingham with the appointment of experienced finance solicitor Jon Coane. With more than 27 years’ post-qualified experience, Jon joins the firm as a partner following eight years at Anthony Collins Solicitors. Throughout his career, Jon has focused on...